|
Develop innovative products
Arandi brings new products from concept exploration to completed proof-of-concept trials. In the process we do clinical plans and protocols, applications to ethics committee and regulatory authorities. After careful preparations we coordinate and monitor clinical trials throughout Scandinavia.
The Arandi people provide comprehensive medical, scientific, regulatory, and logistics support for products development. In the past we have successfully tailored our services to the needs of both Big Pharma and many small sponsors. Our track record includes pharma and biotech products, herbaal medicines, and technical devices for medical use.
Design, initiate, and execute clinical trials
Cost-effective management of clinical trials requires a detailed understanding of the patient recruitment process and how study logistics are affected by local market events. Staying on track for the whole course of the trial depends on good relations with local opinion leaders and supporting their staff throughout. We don't believe in being 'virtual' when it comes to site management.
Our competence builds on experience from all aspects of clinical trials throughout Scandinavia for more than two decades. Our regional network helps us to plan yet be quick and flexible. If a sponsor so wishes, we can build ad hoc advisory groups of local experts and specialists,. |
|
Thinking global, acting local
Arandi is based in Stockholm – ‘The Capital of Scandinavia’- and is therefore ideally located to co-ordinate trials in Sweden, Denmark, Norway, Finland and the Baltics. And we have the necessary language skills, professional networks, and detailed understanding of national regulatory processes.
The Nordic countries may have different 'best routines' for patient recruitement and site monitoring. The regulatory processes also differ somewhat. However, our people have the experience to deal with these differences without loss of precious time.
Empower the patient
Arandi invests in life sci projects where our long experience and active involvement can make a difference. We are particularly keen to explore how generic drugs can be incorporated into new formulations so that treatment becomes more effective, more simple, or safer through technology-enabled individual dosing.
The motto for Arandi’s venture projects is “Empower the Patient”. We see great opportunities for IP protected products that enable the patient to take a more active role in treating chronic ailments. Our motto was chosen to show our strong commitment to develop safe medical solutions powered by the needs of the individual. |